Investor World Review
SEE OTHER BRANDS

The latest news on finance and banking

Investor World Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Investor World Review.

Press releases published on May 22, 2025

Is 2025 the Year America Breaks Free from the IRS? Former White House Insider Says the System That’s Trapped Millions Could Soon Collapse

Is 2025 the Year America Breaks Free from the IRS? Former White House Insider Says the System That’s Trapped Millions Could Soon Collapse

WASHINGTON, May 22, 2025 (GLOBE NEWSWIRE) -- A new economic plan quietly gaining momentum in Washington could make 2025 the last year millions of Americans owe the federal government a penny. That’s the claim from Jim Rickards, a former advisor to the CIA, …

إطلاق منصة جديدة مدعومة بالذكاء الاصطناعي لتعزيز توظيف الشباب الإماراتي

إطلاق منصة جديدة مدعومة بالذكاء الاصطناعي لتعزيز توظيف الشباب الإماراتي

إطلاق «مسار الغرير» لتعزيز فرص توظيف الشباب الإماراتي عبر الذكاء الاصطناعي، من خلال مسارات مخصّصة وتوصيات تدريبية وربط مباشر مع سوق العمل DUBAI, UNITED ARAB EMIRATES, May 22, 2025 /⁨EINPresswire.com⁩/ -- 22 مايو 2025 – دبي، الإمارات العربية المتحدة: أطلقت …

New AI-Powered Platform Launched to Boost Emirati Youth Employment

New AI-Powered Platform Launched to Boost Emirati Youth Employment

AI platform Massar Al Ghurair launched to equip Emirati youth with personalized career pathways, future-ready skills, and job-matching tools through ethical AI. DUBAI, UNITED ARAB EMIRATES, May 22, 2025 /⁨EINPresswire.com⁩/ -- The Abdulla Al Ghurair …

Soleno Therapeutics Announces Submission and EMA Validation of Marketing Authorization Application for Diazoxide Choline Prolonged-Release Tablets for the Treatment of Hyperphagia in Patients with Prader-Willi Syndrome

Soleno Therapeutics Announces Submission and EMA Validation of Marketing Authorization Application for Diazoxide Choline Prolonged-Release Tablets for the Treatment of Hyperphagia in Patients with Prader-Willi Syndrome

REDWOOD CITY, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that Soleno’s Marketing Authorization …

FAST TRACK GROUP Announces Pricing of $15 Million Initial Public Offering

FAST TRACK GROUP Announces Pricing of $15 Million Initial Public Offering

SINGAPORE, May 22, 2025 (GLOBE NEWSWIRE) -- FAST TRACK GROUP (“Fast Track” or the “Company”), a leading entertainment-focused event management and celebrity agency company, announced the pricing of its initial public offering of 3,750,000 ordinary shares ( …

Univest Securities, LLC Announces Closing of $5 Million Registered Offering for its Client WORK Medical Technology Group LTD (NASDAQ: WOK)

Univest Securities, LLC Announces Closing of $5 Million Registered Offering for its Client WORK Medical Technology Group LTD (NASDAQ: WOK)

New York, New York, May 22, 2025 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of registered offering …

Kura Oncology and Kyowa Kirin Announce Pivotal Monotherapy Data for Ziftomenib in Oral Presentation at the 2025 ASCO Annual Meeting

Kura Oncology and Kyowa Kirin Announce Pivotal Monotherapy Data for Ziftomenib in Oral Presentation at the 2025 ASCO Annual Meeting

– Results from KOMET-001 registration-directed trial of ziftomenib in R/R NPM1-m AML patients selected for oral presentation on Monday, June 2nd – – Encore presentation planned at EHA 2025 Congress – – Kura Oncology to host virtual investor event at 7:30pm …

PDS Biotech Announces Positive Extended Follow-Up Data for VERSATILE-002 and Additional Trials Evaluating Versamune® HPV to be Presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

PDS Biotech Announces Positive Extended Follow-Up Data for VERSATILE-002 and Additional Trials Evaluating Versamune® HPV to be Presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

Phase 2: Versamune® HPV with pembrolizumab as 1L treatment of r/m HPV16-positive HNSCC - Median overall survival for CPS ≥20 is 39.3 months - Median overall survival for CPS ≥1 is 30.0 months Phase 3: Versamune® HPV with pembrolizumab as 1L treatment of r/ …

RCF Opportunities Fund II L.P. Files Early Warning Report Regarding Common Shares of Defense Metals Corp.

RCF Opportunities Fund II L.P. Files Early Warning Report Regarding Common Shares of Defense Metals Corp.

DENVER, May 22, 2025 (GLOBE NEWSWIRE) -- RCF Opportunities Fund II L.P. (“RCF”) reports that it has filed an early warning report under National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues in respect …

Abcourt annonce ses résultats du troisième trimestre terminé le 31 mars 2025

Abcourt annonce ses résultats du troisième trimestre terminé le 31 mars 2025

ROUYN-NORANDA, Québec, 22 mai 2025 (GLOBE NEWSWIRE) -- Mines Abcourt Inc. (« Abcourt » ou la « Société ») (TSX Venture: ABI) (OTCQB : ABMBF) annonce ses résultats du troisième trimestre terminé le 31 mars 2025. Toutes les valeurs monétaires dans ce …

Abcourt Announces its Results for the Third Quarter Ended March 31, 2025

Abcourt Announces its Results for the Third Quarter Ended March 31, 2025

ROUYN-NORANDA, Quebec, May 22, 2025 (GLOBE NEWSWIRE) -- Abcourt Mines Inc. (“Abcourt” or the “Corporation”) (TSX Venture: ABI) (OTCQB : ABMBF) announces its results for the third quarter ended March 31, 2025. All monetary values in this press release are …

IMUNON Announces Withdrawal of Form S-1 Registration Statement

IMUNON Announces Withdrawal of Form S-1 Registration Statement

LAWRENCEVILLE, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that it has filed a request for withdrawal with the Securities and …

Allogene Therapeutics Announces ASCO 2025 Abstract Publication Featuring Oral Presentation of ALLO-316 in Kidney Cancer and ALPHA3 TIP Poster for Cema-Cel

Allogene Therapeutics Announces ASCO 2025 Abstract Publication Featuring Oral Presentation of ALLO-316 in Kidney Cancer and ALPHA3 TIP Poster for Cema-Cel

SOUTH SAN FRANCISCO, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today …

Daktronics to Participate in the 22nd Annual Craig-Hallum Institutional Investor Conference on May 28th

Daktronics to Participate in the 22nd Annual Craig-Hallum Institutional Investor Conference on May 28th

BROOKINGS, S.D., May 22, 2025 (GLOBE NEWSWIRE) -- Daktronics, Inc. (Nasdaq: DAKT), a leading global designer and manufacturer of best-in-class dynamic video communication displays and control systems for customers worldwide today announced that Brad …

Cullinan Therapeutics, Taiho Pharmaceutical, and Taiho Oncology to Present Positive Results from Pivotal Phase 2b REZILIENT1 Trial of Zipalertinib at ASCO 2025

Cullinan Therapeutics, Taiho Pharmaceutical, and Taiho Oncology to Present Positive Results from Pivotal Phase 2b REZILIENT1 Trial of Zipalertinib at ASCO 2025

CAMBRIDGE, Mass. and TOKYO, Japan and PRINCETON, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), Taiho Pharmaceutical Co., Ltd., and Taiho Oncology, Inc. today announced new positive results from the pivotal Phase 2b …

Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT

Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT

An oral presentation at ASCO …

Petrus Announces Results of Annual General Meeting of Shareholders

Petrus Announces Results of Annual General Meeting of Shareholders

CALGARY, Alberta, May 22, 2025 (GLOBE NEWSWIRE) -- Petrus Resources Ltd. ("Petrus" or the "Company") (TSX: PRQ) is pleased to announce that its shareholders approved all resolutions at its annual general meeting of shareholders held yesterday (the "Meeting …

Acceleware Ltd. Reports First Quarter 2025 Financial and Operating Results

Acceleware Ltd. Reports First Quarter 2025 Financial and Operating Results

CALGARY, Alberta, May 22, 2025 (GLOBE NEWSWIRE) -- Acceleware® Ltd. (“Acceleware” or the “Company”) (TSX-V: AXE), an advanced electromagnetic (“EM”) heating company with highly scalable solutions for large industrial applications, today announced its …

Linvoseltamab in Combination with Carfilzomib or Bortezomib Shows Promising Initial Results in Earlier Lines of Treatment for Relapsed/Refractory Multiple Myeloma

Linvoseltamab in Combination with Carfilzomib or Bortezomib Shows Promising Initial Results in Earlier Lines of Treatment for Relapsed/Refractory Multiple Myeloma

First results to be presented in two ASCO oral presentations Data in both combinations demonstrate high response rates TARRYTOWN, N.Y., May 22, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced initial results from two …

CH4 Global Unleashes Seaweed's Power to Combat Livestock Methane Emissions at Scale

CH4 Global Unleashes Seaweed's Power to Combat Livestock Methane Emissions at Scale

HENDERSON, NV, UNITED STATES, May 22, 2025 /⁨EINPresswire.com⁩/ -- CH4 Global is pioneering the use of Asparagopsis seaweed to dramatically reduce methane emissions from cattle, offering a powerful, nature-based solution to one of agriculture's most …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service